PURCHASE ORDER
Active75N98026P01356
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH OLAO
$346.3K
obligated · signed 2 months ago
MOLECULAR DIAGNOSTIC TESTING
Performance timeline
Start
Aug 19, 2026
End
Aug 18, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Aug 18, 2027
ROCHE DIAGNOSTICS CORPORATION
Contract 75N98026P01356
UEI
JDMDFEZBYH36
Parent Company
ROCHE HOLDING AG
Capabilities & Certifications
Headquarters Location
Congressional District: 07
Current Obligation
$346,255
Base + Exercised Options
$346,255
Total Ceiling Value
$346,255
Contract Type
FIRM FIXED PRICE
NAICS
OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
PSC
IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Place of Performance
Congressional District: 07
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH OLAO
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH - CC
Office
Solicitation procedures, competition exceptions, labor standards and account totals.